CD5 and breast cancer: In luminal breast cancer primary tumors, Bourdely et al. have shown that a population of inflammatory DCs CD11c+ FCeRI+ CD14+ CD5− CD1c+ completely aligned phenotypically with the DC3 and their presence correlates with the abundance of CD8+CD103+CD69+ tissue-resident memory T cells [100].